Toward a better understanding of pharmacokinetics of nanomaterials

Chengke Zhang, Qiu Zhang, Yi Zhang, Bing Yan

Research output: Contribution to journalReview article

Abstract

Nanotechnology has promising applications in biomedicine, such as in drug delivery, diagnosis, and tissue engineering. The pharmacokinetics of nanomaterials significantly affects their biological behavior in vivo, affecting their biomedical applications and potential nanotoxicity. In this review, we highlight some recent advances in the pharmacokinetic studies of representative nanomaterials. We focus on the relationships between the physicochemical properties of nanomaterials and physiological consequences.

Original languageEnglish (US)
Pages (from-to)6667-6680
Number of pages14
JournalCurrent pharmaceutical design
Volume19
Issue number37
DOIs
StatePublished - Nov 25 2013
Externally publishedYes

Fingerprint

Nanostructures
Tissue Distribution
Drug Delivery Systems
Pharmacokinetics
Nanotechnology
Tissue Engineering
Pharmaceutical Preparations

Keywords

  • Absorption
  • Distribution
  • Excretion
  • Metabolism
  • Nanomaterials
  • Pharmacokinetics

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Toward a better understanding of pharmacokinetics of nanomaterials. / Zhang, Chengke; Zhang, Qiu; Zhang, Yi; Yan, Bing.

In: Current pharmaceutical design, Vol. 19, No. 37, 25.11.2013, p. 6667-6680.

Research output: Contribution to journalReview article

Zhang, Chengke ; Zhang, Qiu ; Zhang, Yi ; Yan, Bing. / Toward a better understanding of pharmacokinetics of nanomaterials. In: Current pharmaceutical design. 2013 ; Vol. 19, No. 37. pp. 6667-6680.
@article{fd68ddb310064435b1da303bcde7a371,
title = "Toward a better understanding of pharmacokinetics of nanomaterials",
abstract = "Nanotechnology has promising applications in biomedicine, such as in drug delivery, diagnosis, and tissue engineering. The pharmacokinetics of nanomaterials significantly affects their biological behavior in vivo, affecting their biomedical applications and potential nanotoxicity. In this review, we highlight some recent advances in the pharmacokinetic studies of representative nanomaterials. We focus on the relationships between the physicochemical properties of nanomaterials and physiological consequences.",
keywords = "Absorption, Distribution, Excretion, Metabolism, Nanomaterials, Pharmacokinetics",
author = "Chengke Zhang and Qiu Zhang and Yi Zhang and Bing Yan",
year = "2013",
month = "11",
day = "25",
doi = "10.2174/1381612811319370010",
language = "English (US)",
volume = "19",
pages = "6667--6680",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "37",

}

TY - JOUR

T1 - Toward a better understanding of pharmacokinetics of nanomaterials

AU - Zhang, Chengke

AU - Zhang, Qiu

AU - Zhang, Yi

AU - Yan, Bing

PY - 2013/11/25

Y1 - 2013/11/25

N2 - Nanotechnology has promising applications in biomedicine, such as in drug delivery, diagnosis, and tissue engineering. The pharmacokinetics of nanomaterials significantly affects their biological behavior in vivo, affecting their biomedical applications and potential nanotoxicity. In this review, we highlight some recent advances in the pharmacokinetic studies of representative nanomaterials. We focus on the relationships between the physicochemical properties of nanomaterials and physiological consequences.

AB - Nanotechnology has promising applications in biomedicine, such as in drug delivery, diagnosis, and tissue engineering. The pharmacokinetics of nanomaterials significantly affects their biological behavior in vivo, affecting their biomedical applications and potential nanotoxicity. In this review, we highlight some recent advances in the pharmacokinetic studies of representative nanomaterials. We focus on the relationships between the physicochemical properties of nanomaterials and physiological consequences.

KW - Absorption

KW - Distribution

KW - Excretion

KW - Metabolism

KW - Nanomaterials

KW - Pharmacokinetics

UR - http://www.scopus.com/inward/record.url?scp=84887923610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887923610&partnerID=8YFLogxK

U2 - 10.2174/1381612811319370010

DO - 10.2174/1381612811319370010

M3 - Review article

C2 - 23621528

AN - SCOPUS:84887923610

VL - 19

SP - 6667

EP - 6680

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 37

ER -